TY - JOUR A1 - Geißler, Daniel A1 - Wegner, Karl David A1 - Fischer, C. A1 - Resch-Genger, Ute T1 - Exploring Simple Particle-Based Signal Amplification Strategies in a Heterogeneous Sandwich Immunoassay with Optical Detection N2 - Heterogeneous sandwich immunoassays are widely used for biomarker detection in bioanalysis and medical diagnostics. The high analyte sensitivity of the current “gold standard” enzyme-linked immunosorbent assay (ELISA) originates from the signal-generating enzymatic amplification step, yielding a high number of optically detectable reporter molecules. For future point-of-care testing (POCT) and point-of-need applications, there is an increasing interest in more simple detection strategies that circumvent time-consuming and temperature-dependent enzymatic reactions. A common concept to aim for detection limits comparable to those of enzymatic amplification reactions is the usage of polymer nanoparticles (NP) stained with a large number of chromophores. We explored different simple NP-based signal amplification strategies for heterogeneous sandwich immunoassays that rely on an extraction-triggered release step of different types of optically detectable reporters. Therefore, streptavidinfunctionalized polystyrene particles (PSP) are utilized as carriers for (i) the fluorescent dye coumarin 153 (C153) and (ii) hemin (hem) molecules catalyzing the luminol reaction enabling chemiluminescence (CL) detection. Additionally, (iii) NP labeling with hemin-based microperoxidase MP11 was assessed. For each amplification approach, the PSP was first systematically optimized regarding size, loading concentration, and surface chemistry. Then, for an immunoassay for the inflammation marker C- eactive protein (CRP), the analyte sensitivity achievable with optimized PSP ystems was compared with the established ELISA concept for photometric and CL detection. Careful optimization led to a limit of detection (LOD) of 0.1 ng/mL for MP11-labeled PSP and CL detection, performing similarly well to a photometric ELISA (0.13 ng/mL), which demonstrates the huge potential of our novel assay concept. KW - Nanoparticle KW - Fluorescence KW - Immunoassay KW - Quality assurance KW - Antibody KW - Polymer KW - Dye KW - Signal enhancement KW - CRP KW - Biosensing PY - 2024 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-597853 DO - https://doi.org/10.1021/acs.analchem.3c03691 SN - 1520-6882 VL - 96 IS - 13 SP - 5078 EP - 5085 PB - American Chemical Society CY - Columbus, Ohio AN - OPUS4-59785 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Yu, Z. A1 - Musnier, B. A1 - Wegner, Karl David A1 - Henry, M. A1 - Chovelon, B. A1 - Desroches-Castan, A. A1 - Fertin, A. A1 - Resch-Genger, Ute A1 - Bailly, S. A1 - Coll, J.-L. A1 - Usson, Y, A1 - Josserand, V. A1 - Le Gúevel, X. T1 - High-Resolution Shortwave Infrared Imaging of Vascular Disorders Using Gold Nanoclusters N2 - We synthesized a generation of water-soluble, atomically precise gold nanoclusters (Au NCs) with anisotropic Surface containing a short dithiol pegylated chain (AuMHA/TDT). The AuMHA/TDT exhibit a high brightness (QY ∼ 6%) in the shortwave infrared (SWIR) spectrum with a detection above 1250 nm. Furthermore, they show an extended half-life in blood (t1/2ß = 19.54 ± 0.05 h) and a very weak accumulation in organs. We also developed a non-invasive, whole-body vascular imaging system in the SWIR window with high-resolution, benefiting from a series of Monte Carlo image processing. The imaging process enabled to improve contrast by 1 order of magnitude and enhance the spatial Resolution by 59%. After systemic administration of these nanoprobes in mice, we can quantify vessel complexity in depth (>4 mm), allowing to detect very subtle vascular disorders non-invasively in bone morphogenetic protein 9 (Bmp9)-deficient mice. The combination of these anisotropic surface charged Au NCs plus an improved SWIR imaging device allows a precise mapping at high-resolution and an in depth understanding of the organization of the vascular network in live animals. KW - Nanoparticle KW - Nanosensor KW - Fluorescence KW - Metal cluster KW - NIR KW - SWIR KW - Photophysics KW - Ligand KW - Size KW - Surface chemistry KW - Quantum yield KW - Mechanism KW - Lifetime KW - Decay kinetics PY - 2020 DO - https://doi.org/10.1021/acsnano.0c01174 VL - 14 IS - 4 SP - 4973 EP - 4981 PB - ACS Publication AN - OPUS4-50671 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Chazeau, E. A1 - Pipier, A. A1 - Wegner, Karl David A1 - Ghiringhelli, F. A1 - Sancey, L. A1 - Paul, C. A1 - Goze, C. T1 - NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate N2 - Real-time imaging of antibody-drug conjugates (ADCs) offers valuable insights for assessing tumor targeting specificity, monitoring therapeutic efficacy, and detecting off-target accumulation that may cause adverse effects. To enable precise tracking, we developed a versatile fluorescent platform based on an NIR-II emitting aza-BODIPY dye, which can be site-specifically grafted onto an IgG1 antibody to generate well-defined fluorescent ADCs. As a proof of concept, we synthesized an HER2-targeting trastuzumab immunoconjugate bearing a NIR-II aza-BODIPY fluorophore. The cytotoxic monomethyl auristatin E (MMAE) payload was introduced in the final step, resulting in a trackable and homogeneous ADC suitable for both in vitro and in vivo investigations. The resulting Trastu-azaNIRII-MMAE selectively accumulated in HER2-positive subcutaneous tumors, significantly reducing the tumor growth. Using NIR-II optical imaging, a single injection of the NIR-II-ADC allowed for the detection of the conjugate over a period of more than one month, highlighting its potential for long-term tracking and therapeutic applications. KW - NIR-II KW - Fluorescence KW - Quality assurance KW - Antibody drug conjugate KW - In vivo imaging PY - 2025 DO - https://doi.org/10.1021/acs.jmedchem.4c02777 VL - 68 IS - 7 SP - 7232 EP - 7242 PB - ACS Publications AN - OPUS4-63025 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Wang, Z. A1 - Wegner, Karl David A1 - Stiegler, L. M. S. A1 - Zhou, X. A1 - Rezvani, A. A1 - Odungat, A. S. A1 - Zubiri, B. A. A1 - Wu, M. A1 - Spiecker, E. A1 - Walter, J. A1 - Resch-Genger, Ute A1 - Segets, D. T1 - Optimizing the Shelling Process of InP/ZnS Quantum Dots Using a Single-Source Shell Precursor: Implications for Lighting and Display Applications N2 - InP/ZnS core/shell quantum dots (QDs), recognized as highly promising heavy-metal-free emitters, are increasingly being utilized in lighting and display applications. Their synthesis in a tubular flow reactor enables production in a highly efficient, scalable, and reproducible manner, particularly when combined with a single-source shell precursor, such as zinc diethyldithiocarbamate (Zn(S2CNEt2)2). However, the photoluminescence quantum yield (PLQY) of QDs synthesized with this route remains significantly lower compared with those synthesized in batch reactors involving multiple steps for the shell growth. Our study identifies the formation of absorbing, yet nonemissive ZnS nanoparticles during the ZnS shell formation process as a main contributing factor to this discrepancy. By varying the shelling conditions, especially the shelling reaction temperature and InP core concentration, we investigated the formation of pure ZnS nanoparticles and their impact on the optical properties, particularly PLQY, of the resultant InP/ZnS QDs through ultraviolet−visible (UV−vis) absorption, steady-state and time-resolved photoluminescence (PL) spectroscopy, scanning transmission electron microscopy (STEM), and analytical ultracentrifugation (AUC) measurements. Our results suggest that process conditions, such as lower shelling temperatures or reduced InP core concentrations (resulting in a lower external surface area), encourage homogeneous nucleation of ZnS. This reduces the availability of shell precursors necessary for effective passivation of the InP core surfaces, ultimately resulting in lower PLQYs. These findings explain the origin of persistently underperforming PLQY of InP/ZnS QDs synthesized from this synthesis route and suggest further optimization strategies to improve their emission for lighting and display applications. KW - Nano KW - Particle KW - Synthesis KW - InP KW - Shell KW - Fluorescence KW - Quantum yield KW - ZnS KW - Semiconductor KW - Quantum dot KW - Flow reactor KW - Method KW - AUC KW - Size KW - Automation KW - Sensor PY - 2024 DO - https://doi.org/10.1021/acsanm.4c05265 SN - 2574-0970 VL - 7 IS - 20 SP - 24262 EP - 24273 PB - ACS Publications AN - OPUS4-61518 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Kang, Y. A1 - Nack, L. M. A1 - Liu, Y. A1 - Qi, B. A1 - Huang, Y. A1 - Liu, Z. A1 - Chakraborty, I. A1 - Schulz, F. A1 - Ahmed, A. A. A. A1 - Poveda, M. C. A1 - Hafizi, F. A1 - Roy, S. A1 - Mutas, M. A1 - Holzapfel, M. A1 - Sanchez-Cano, C. A1 - Wegner, Karl David A1 - Feliu, N. A1 - Parak, W. J. T1 - Quantitative considerations about the size dependence of cellular entry and excretion of colloidal nanoparticles for different cell types N2 - Most studies about the interaction of nanoparticles (NPs) with cells have focused on how the physicochemical properties of NPs will influence their uptake by cells. However, much less is known about their potential excretion from cells. However, to control and manipulate the number of NPs in a cell, both cellular uptake and excretion must be studied quantitatively. Monitoring the intracellular and extracellular amount of NPs over time (after residual noninternalized NPs have been removed) enables one to disentangle the influences of cell proliferation and exocytosis, the major pathways for the reduction of NPs per cell. Proliferation depends on the type of cells, while exocytosis depends in addition on properties of the NPs, such as their size. Examples are given herein on the role of these two different processes for different cells and NPs. KW - Cell proliferation KW - Exocytosis KW - Gold nanoparticles KW - Quantum dots KW - Fluorescence KW - Uptake studies PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-543476 DO - https://doi.org/10.1007/s40828-021-00159-6 SN - 2199-3793 VL - 8 IS - 1 SP - 1 EP - 8 PB - Springer CY - Berlin AN - OPUS4-54347 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Bertorelle, F. A1 - Wegner, Karl David A1 - Berkulic, M. P. A1 - Fakhouri, H. A1 - Comby-Zerbino, C. A1 - Sagar, A. A1 - Bernadó, P. A1 - Resch-Genger, Ute A1 - Bonacic-Koutecký, V. A1 - Le Guével, X. A1 - Antoine, R. T1 - Tailoring the NIR-II Photoluminescence of Single Thiolated Au25 Nanoclusters by Selective Binding to Proteins N2 - Atomically precise gold nanoclusters are a fascinating class of nanomaterials that exhibit molecule-like properties and have outstanding photoluminescence (PL). Their ultrasmall size, molecular chemistry, and biocompatibility make them extremely appealing for selective biomolecule labeling in investigations of biological mechanisms at the cellular and anatomical levels. In this work, we report a simple route to incorporate a preformed Au25 nanocluster into a model bovine serum albumin (BSA) protein. A new approach combining small-angle X-ray scattering and molecular modeling provides a clear localization of a single Au25 within the protein to a cysteine residue on the gold nanocluster surface. Attaching Au25 to BSA strikingly modifies the PL properties with enhancement and a redshift in the second near-infrared (NIR-II) window. This study paves the way to conrol the design of selective sensitive probes in biomolecules through a ligand-based strategy to enable the optical detection of biomolecules in a cellular environment by live imaging. KW - Fluorescence KW - Aggregation KW - Signal enhancement KW - Cluster KW - Nano KW - Metal KW - NIRII KW - SWIR KW - Sensor KW - Quantum yield KW - Lifetime KW - Photophysics KW - Synthesis KW - Protein KW - Imaging KW - Bioimaging KW - Ligand KW - Gold PY - 2022 DO - https://doi.org/10.1002/chem.202200570 SN - 1521-3765 VL - 28 IS - 39 SP - 1 EP - 8 PB - Wiley-VCH CY - Weinheim AN - OPUS4-55077 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Bhuckory, S. A1 - Wegner, Karl David A1 - Qiu, X. A1 - Wu, Y.T. A1 - Jennings, T. L. A1 - Incamps, A. A1 - Hildebrandt, N. T1 - Triplexed CEA-NSE-PSA Immunoassay Using Time-Gated Terbium-to-Quantum Dot FRET N2 - Time-gated Förster resonance energy transfer (TG-FRET) between Tb complexes and luminescent semiconductor quantum dots (QDs) provides highly advantageous photophysical properties for multiplexed biosensing. Multiplexed Tb-to-QD FRET immunoassays possess a large potential for in vitro diagnostics, but their performance is often insufficient for their application under clinical conditions. Here, we developed a homogeneous TG-FRET immunoassay for the quantification of carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), and prostatespecific antigen (PSA) from a single serum sample by multiplexed Tb-to-QD FRET. Tb–IgG antibody donor conjugates were combined with compact QD-F(ab’)2 antibody acceptor conjugates with three different QDs emitting at 605, 650, and 705 nm. Upon antibody–antigen–antibody Sandwich complex formation, the QD acceptors were sensitized via FRET from Tb, and the FRET ratios of QD and Tb TG luminescence intensities increased specifically with increasing antigen concentrations. Although limits of detection (LoDs: 3.6 ng/mL CEA, 3.5 ng/mL NSE, and 0.3 ng/mL PSA) for the triplexed assay were slightly higher compared to the single-antigen assays, they were still in a clinically relevant concentration range and could be quantified in 50 μL serum samples on a B·R·A·H·M·S KRYPTOR Compact PLUS clinical immunoassay plate reader. The simultaneous quantification of CEA, NSE, and PSA at different concentrations from the same serum sample demonstrated actual multiplexing Tb-to-QD FRET immunoassays and the potential of this technology for translation into clinical diagnostics. KW - Lanthanides KW - Nanoparticles KW - Biosensing KW - Multiplexing KW - FRET KW - Fluorescence KW - PSA KW - NSE KW - CEA PY - 2020 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-512290 DO - https://doi.org/10.3390/molecules25163679 VL - 25 IS - 16 SP - 3679 PB - MDPI AN - OPUS4-51229 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -